China Pharma (CPHI) gets NYSE American deficiency notice; avg price below $0.20, must cure by March 2023

CHINA PHARMA HOLDINGS, INC.

Average stock price below $0.20 over 30 days as of Sept 22, 2022 triggers continued listing noncompliance.
NYSE American requires reverse stock split or sustained price improvement by March 26, 2023 to maintain listing.
Company also subject to prior stockholders' equity noncompliance letter from June 2022.
Stock continues trading on NYSE American while company pursues compliance measures.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.